Abiomed
ABMD
#1118
Rank
NZ$28.76 B
Marketcap
$638.02
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

EPS for Abiomed (ABMD)

EPS in 2022 (TTM): $9.39

According to Abiomed's latest financial reports the company's current EPS (TTM) is $9.85. In 2021 the company made an earnings per share (EPS) of $4.91 a decrease over its 2020 EPS that were of $7.45.

EPS history for Abiomed from 2013 to 2022

Annual EPS

Year EPS Change
2022 (TTM)$9.3991.37%
2021$4.91-34.16%
2020$7.45-18.05%
2019$9.099.48%
2018$8.31141.95%
2017$3.4381.42%
2016$1.89-62.83%
2015$5.09575.56%
2014$0.75125%
2013$0.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$14.40 46.26%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.37-86.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.90-109.18%๐Ÿ‡บ๐Ÿ‡ธ USA